Normunity appoints industry leader Debanjan Ray to Board of Directors

BOSTON & WEST HAVEN, Conn.–(BUSINESS WIRE)–Normunity, Inc., a biotechnology company creating novel precision anti-cancer immunotherapies, today announced the appointment of Debanjan Ray, MBA, to its board of directors. Mr. Ray currently serves as President and Chief Executive Officer of Synthekine, and he has served in leadership roles for multiple biotechnology companies. “We are excited to welcome Debanjan to our Board of Directors, as he brings exceptional strategic, operational, and trans

Recent Articles